PEAK1 anticorps (N-Term)
Aperçu rapide pour PEAK1 anticorps (N-Term) (ABIN7184503)
Antigène
Voir toutes PEAK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from N-terminal of Human SGK269.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:3000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PEAK1 (Pseudopodium-Enriched Atypical Kinase 1 (PEAK1))
-
Autre désignation
- PEAK1
-
Sujet
-
Background: Tyrosine kinase that may play a role in cell spreading and migration on fibronectin. May directly or indirectly affect phosphorylation levels of cytoskeleton-associated proteins MAPK1/ERK and PXN.
Zody M.C., Nature 440:671-675(2006).
Jikuya H., Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
Ohara O., DNA Res. 9:47-57(2002).Aliases: FLJ21140 antibody, FLJ34483 antibody, KIAA2002 antibody, NKF3 kinase family member antibody, PEAK1 antibody, PEAK1_HUMAN antibody, pseudopodium enriched atypical kinase antibody, Pseudopodium-enriched atypical kinase 1 antibody, SGK269 antibody, Sugen kinase 269 antibody, Tyrosine-protein kinase SgK269 antibody
-
UniProt
- Q9H792
Antigène
-